Matches in Wikidata for { <http://www.wikidata.org/entity/Q60230363> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q60230363 description "im August 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60230363 description "scholarly article by Petra Heffeter et al published 1 August 2015 in Cancer Research" @default.
- Q60230363 description "wetenschappelijk artikel" @default.
- Q60230363 description "наукова стаття, опублікована в серпні 2015" @default.
- Q60230363 name "Abstract 4397: Preclinical development of a novel hypoxia-activated EGFR inhibitor using a cobalt" @default.
- Q60230363 name "Abstract 4397: Preclinical development of a novel hypoxia-activated EGFR inhibitor using a cobalt(III)-based prodrug design" @default.
- Q60230363 type Item @default.
- Q60230363 label "Abstract 4397: Preclinical development of a novel hypoxia-activated EGFR inhibitor using a cobalt" @default.
- Q60230363 label "Abstract 4397: Preclinical development of a novel hypoxia-activated EGFR inhibitor using a cobalt(III)-based prodrug design" @default.
- Q60230363 prefLabel "Abstract 4397: Preclinical development of a novel hypoxia-activated EGFR inhibitor using a cobalt" @default.
- Q60230363 prefLabel "Abstract 4397: Preclinical development of a novel hypoxia-activated EGFR inhibitor using a cobalt(III)-based prodrug design" @default.
- Q60230363 P1433 Q60230363-75F62456-1CD9-449C-A1C0-8A2DD146E84C @default.
- Q60230363 P1476 Q60230363-F45C91B2-8D91-4177-AD2F-2FBA5316945B @default.
- Q60230363 P2093 Q60230363-112DFDDE-6BD4-4FC2-9997-09D1AA8AE04F @default.
- Q60230363 P2093 Q60230363-4B45672B-2920-407E-A724-374442B3725E @default.
- Q60230363 P2093 Q60230363-6FAC7C85-E2A4-41E2-B87C-0466F6E51BA9 @default.
- Q60230363 P2093 Q60230363-92F0253C-C34B-4DFF-B535-54DB19238E34 @default.
- Q60230363 P2093 Q60230363-B3DB999E-7830-4BD4-A2E5-660493F5C2E5 @default.
- Q60230363 P2093 Q60230363-CD596CBF-E948-41CB-B35C-EE2C33DFB9B5 @default.
- Q60230363 P304 Q60230363-83EB08E9-D83B-4CCC-B41A-9EE58CD35FF1 @default.
- Q60230363 P31 Q60230363-18835EFD-DD6A-49A7-89A2-6841D2EC5134 @default.
- Q60230363 P356 Q60230363-BAD73443-5799-4404-A1C5-79E7902F87E1 @default.
- Q60230363 P407 Q60230363-EBADFD23-6A5B-4B56-A401-3ABD18786392 @default.
- Q60230363 P433 Q60230363-E35F276F-AD9A-44FA-95BA-51A9EFA0F6BA @default.
- Q60230363 P478 Q60230363-EA8D2D0C-2636-407C-9707-6E2B035BFBF5 @default.
- Q60230363 P50 Q60230363-A19D7C36-485F-411D-BF01-9ECDC8A08D84 @default.
- Q60230363 P577 Q60230363-3D827F30-6965-4E7C-9152-A3D0ABB290D0 @default.
- Q60230363 P921 Q60230363-872f916e-f85d-4fc2-9386-ad678bc6e4e5 @default.
- Q60230363 P356 1538-7445.AM2015-4397 @default.
- Q60230363 P1433 Q326097 @default.
- Q60230363 P1476 "Abstract 4397: Preclinical development of a novel hypoxia-activated EGFR inhibitor using a cobalt(III)-based prodrug design" @default.
- Q60230363 P2093 "Bernhard K. Keppler" @default.
- Q60230363 P2093 "Christian R. Kowol" @default.
- Q60230363 P2093 "Claudia Karnthaler-Benbakka" @default.
- Q60230363 P2093 "Diana Groza" @default.
- Q60230363 P2093 "Kushtrim Kryeziu" @default.
- Q60230363 P2093 "Walter Berger" @default.
- Q60230363 P304 "4397-4397" @default.
- Q60230363 P31 Q13442814 @default.
- Q60230363 P356 "10.1158/1538-7445.AM2015-4397" @default.
- Q60230363 P407 Q1860 @default.
- Q60230363 P433 "15 Supplement" @default.
- Q60230363 P478 "75" @default.
- Q60230363 P50 Q42173445 @default.
- Q60230363 P577 "2015-08-01T00:00:00Z" @default.
- Q60230363 P921 Q740 @default.